Clinical and Translational oncology

Cost–utility analysis of germline BRCA1/2 testing in women with high‑grade epithelial ovarian cancer in Spain

Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010

Escriba su búsqueda